Fund moves

Medtronic (MDT)Gradient Investments LLC added to its stake +19K shares

Gradient Investments LLC added to its stake in Medtronic, per its Q2 2026 13F.

497K
Shares reported · +19K vs prior quarter
0.54%
Disclosed portfolio weight
$38.8M
Reported value
Holdings as of
Jun 30, 2026
Filed
Jul 8, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 7, 2025CongressDisclosed partial sale of MDT — reported range $1,001 - $15,000
  2. Mar 27, 2026CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
  3. May 15, 2026CongressDisclosed partial sale of MDT — reported range $1,001 - $15,000
  4. May 18, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On May 18, 2026, Medtronic plc (“Medtronic” or the “Company”) announced that Brett Wall will be departing from his position as Executive Vice President and President, Neuroscience Portfolio, and that Dr. Kweli Thompson, currently Senior Vice President and President, Cardiac Rhythm Management, will be assuming the role of Executive Vice President and President, Neuroscience Portfolio, effective June 1, 2026.”
  5. Jun 3, 2026Company filing · Form 8-K · ResultsReported its results
  6. Jun 8, 2026Insider · 1 personInsiders: 2 sales (~$337K)
  7. Jul 8, 2026InsiderOfficer sold ~$258K of MDT shares in the open market

What came next

  1. Jul 9, 2026FDAFDA device clearance: SmartGuard Technology; Predictive Low Glucose Technology
  2. Jul 13, 2026FDARecall: MiniMed 780G Insulin Pump, Model: MMT-1885CLW, MMT-1886CLW
  3. Jul 13, 2026FDARecall: MiniMed 670G Insulin Pump, Model: MMT-1781, MMT-1782;
  4. Jul 13, 2026FDARecall: MiniMed 640G Insulin Pump, Model: MMT-1711, MMT-1712;
  5. Jul 14, 2026FDAFDA device clearance: Symmetrix™ L Spinal System
  6. Jul 17, 2026FDAFDA device clearance: Catalyft PL Expandable Interbody System
  7. Jul 27, 2026FDAFDA device clearance: Euphora Rapid Exchange (RX) Balloon Dilatation Catheter
  8. Jul 30, 2026CongressDisclosed sale of MDT — reported range $1,001 - $15,000
  9. Jul 31, 2026FDAFDA device clearance: VitalFlow Set with Balance™ Biosurface
  10. Aug 13, 2026FDAFDA device clearance: BIS™ Advance pEEG Module
  11. Aug 14, 2026FDAFDA device clearance: NC Euphora Rapid Exchange Balloon Dilatation Catheter
  12. Aug 21, 2026FDAFDA device clearance: Affera Integrated Mapping System
  13. Aug 24, 2026CongressDisclosed sale of MDT — reported range $15,001 - $50,000
  14. Aug 28, 2026FDAFDA device clearance: LINQ II Insertable Cardiac Monitor (ICM) (LNQ22)
  15. Sep 1, 2026Company filing · Form 8-K · ResultsReported its results
  16. Sep 4, 2026FDAFDA device clearance: ApexCut ™ Blade with Automated EM Tracking (187BL4012EM);ApexCut ™ Blade with Automated EM Tracking (187BL4040EM);ApexCut ™ Blade with Automated EM Tracking (1…
  17. Sep 15, 2026FDAFDA device clearance: LigaSure™ RAS Maryland Jaw Vessel Sealer/Divider, Nano-coated
  18. Sep 16, 2026InsiderOfficer sold ~$139K of MDT shares in the open market
  19. Sep 17, 2026FDAFDA device clearance: Protégé™ EverFlex™ Self-expanding Peripheral Stent System
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Medtronic

For Medtronic, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports and 50 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MDT page.

How this filing works

Other disclosures at Medtronic

Everything OQRO holds on this company is on its MDT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data